Corporate VC units GE Ventures and Sanofi Ventures both invested to help the health behaviour tracker take its funding to $61m altogether.
US-based health behaviour tracking platform Evidation Health has received $30m in a series C round featuring power and industrial technology producer General Electric (GE) and pharmaceutical firm Sanofi.
B Capital Group, the venture capital firm backed by consulting firm Boston Consulting, co-led the round with VC firm SV Health Investors, while the corporates invested through subsidiaries GE Ventures and Sanofi Ventures respectively.
Formed in 2012 through a partnership between GE Ventures and Stanford University, Evidation has built a software platform…
